CDC Issues Recommendations for Healthcare Facilities Seeking to Ensure Adequate Supply of PPE

News
Article

A recent increase in demand for personal protective equipment (PPE) has caused delays for some products ordered by U.S. hospitals for Ebola preparedness. Across the United States, availability for these products varies by product type and model, manufacturer, distributor, and geographic region.

According to the Centers for Disease Control and Prevention (CDC), there are a number of options available for hospitals needing to increase their PPE supplies despite manufacturer shortages and delays. The role a hospital plays in preparing to identify, isolate, evaluate, and, in some cases, treat patients with possible Ebola virus disease is the most important indicator of how much PPE is needed. (See Interim Guidance for U.S. Hospital Preparedness for Patients with Possible or Confirmed Ebola Virus Disease: A Framework for a Tiered Approach for more information on hospitals roles.)

To provide state health departments and hospitals with more information on how to increase PPE supply, CDC has issued the following guidance, Considerations for U.S Healthcare Facilities to Ensure Adequate Supplies of Personal Protective Equipment (PPE) for Ebola Preparedness. This resource summarizes the current U.S. PPE supply situation and provides recommendations for ways healthcare facilities can increase PPE as part of their Ebola preparedness planning efforts.

Source: CDC

Recent Videos
 Darren Goff, executive director of hospitality services at Cameron Memorial Community Hospital in Angola, Indiana.
Isis Lamphier, MPH, MHA, CIC; Tori Whitacre Martonicz, MA; and Heather Stoltzfus, MPH, RN, CIC, at APIC Conference and Expo 2024 (Photo courtesy of Tori Whitacre Martonicz)
Lindsay K. Weir, MPH, CIC, Lead Infection Preventionist/Infection Preventionist III
•	Rebecca (Bartles) Crapanzano-Sigafoos, DrPH, MPH, CIC, FAPIC (corresponding author), executive director of APIC’s Center for Research, Practice, and Innovation, and lead author of the study.
Infection Control Today's Infection Intel: Staying Ahead With Company Updates and Product Innovations.
COVID-19 presentations at IDWeek in Las Angeles, California by Invivyd.   (Adobe Stock 333039083 by Production Perig)
Long COVID and Other Post-Viral Syndromes
Meet Jenny Hayes, MSN, RN, CIC, CAIP, CASSPT.
Infection Control Today Editorial Advisory Board: Fibi Attia, MD, MPH, CIC.
Andrea Thomas, PhD, DVM, MSc, BSc, director of epidemiology at BlueDot
Related Content